323 related articles for article (PubMed ID: 8437967)
1. Omeprazole: a comprehensive review.
Massoomi F; Savage J; Destache CJ
Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility and safety of omeprazole.
Walan A
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole: a new approach to gastric acid suppression.
Buhl K; Clearfield HR
Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
[TBL] [Abstract][Full Text] [Related]
4. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
8. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Barradell LB; Faulds D; McTavish D
Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with omeprazole: assessment of efficacy and safety.
Walan A
J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
[TBL] [Abstract][Full Text] [Related]
10. [Substituted benzimidazoles--a new dimension in ulcer therapy?].
Fimmel CJ; Blum AL
Wien Klin Wochenschr; 1984 Feb; 96(4):149-53. PubMed ID: 6324498
[TBL] [Abstract][Full Text] [Related]
11. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
12. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
Sosnowski M
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
[No Abstract] [Full Text] [Related]
13. The role of omeprazole in healing and prevention of reflux disease.
Klinkenberg-Knol EC
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
[TBL] [Abstract][Full Text] [Related]
14. [Omeprazole. Its pharmacology and therapeutic efficacy].
Protzer U; Holtermüller KH
Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
[No Abstract] [Full Text] [Related]
15. [Omeprazole].
Isal JP
Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
[No Abstract] [Full Text] [Related]
16. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Bown RL
Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
[TBL] [Abstract][Full Text] [Related]
17. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
18. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
Meijer JL; Jansen JB; Lamers CB
Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole.
Walan A
Baillieres Clin Gastroenterol; 1988 Jul; 2(3):629-40. PubMed ID: 3048454
[No Abstract] [Full Text] [Related]
20. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
